The "EXONHIT" trademark, serial number 79111670 , was filed on 30th of November 2011 with a mark drawing code of 3000 and its transaction date is 79111670. Since 21st of September 2012, the document can be found in the L70 law office in the publication and issue section. The date when we last checked the status of this trademark was 08/27/2012.

Prior registrations: 2625901 , 2721840

The corresponded responsible for this trademark is William C. Wright, located at Epstein Drangel LLP, 60 East 42nd Street, Suite 2410, New York NY 10165.

The state or country where the trademark was organized is by Exonhit S.a.. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at F-75013 Paris, , zip .

GOODS AND/OR SERVICES
International Class - 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
U.S. Class	046 - Foods and Ingredients of Foods
Class Status	6 - Active
Status Date	05/04/2012
Primary Code	001
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class	052 - Detergents and Soaps
Class Status	6 - Active
Status Date	05/04/2012
Primary Code	005
International Class - 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
U.S. Class	044 - Dental, Medical, and Surgical Appliances
Class Status	6 - Active
Status Date	05/04/2012
Primary Code	010
International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
U.S. Class	101 - Advertising and Business
Class Status	6 - Active
Status Date	05/04/2012
Primary Code	042
International Class - 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
U.S. Class	101 - Advertising and Business
Class Status	6 - Active
Status Date	05/04/2012
Primary Code	044
Goods codes
CC0000	The color(s) gray, red and burgundy is/are claimed as a feature of the mark.
DM0000	The mark consists of the wording EXONHIT in stylized format. EXON is in grey and HIT is in burgundy.
GS0011	Chemical products and compositions, namely nucleic acids attached to a solid medium for industrial and scientific use; fissile chemical elements intended for scientific research or laboratory research namely reagents, consumables, chemical entities and compounds; chemical preparations for nucleic acids attached to a solid medium for scientific purposes, chemical preparations for scientific analyses other than for medical or veterinary purposes; biological preparations other than for medical or veterinary purposes, namely blood for the quantification of nucleic acid content; chemical preparations for scientific purposes other than for medical or veterinary use; chemical reagents or products for laboratory analyses namely nucleic acids for monitoring and analyzing the expression of genes, for identifying diagnostic targets and therapeutic products, and for conducting research on pharmacogenetics and genotoxicity in connection with pharmacology, food, chemistry, cosmetology, plant health and veterinary sciences; chemical preparations intended for scientific purposes, namely libraries of nucleic acids for monitoring and analyzing the expression of genes, for identifying diagnostic targets and therapeutic products, and for leading research on pharmacogenetics and genotoxicity in connection with pharmacology, food, chemistry, cosmetology, plant health and veterinary sciences; chemical preparations intended for scientific purposes, namely DNA fragments for decoding genes affected by diseases or for revealing the transcriptomic signature of patients affected by diseases, and DNA fragments for revealing and analyzing the expression of genes in connection with human medicine, pharmacological medicine and veterinary science
GS0051	Pharmaceutical products for the treatment of diseases, namely Alzheimer disease and other neurodegenerative diseases and cancer; reagents and consumables for diagnostic purposes and diagnostic media intended for medical purposes, namely reagents, consumables and media intended for tests, namely tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely pharmaceutical preparations for diagnosing diseases, namely Alzheimer disease and other neurodegenerative diseases and cancer; capsules sold empty for medicines and diagnostic tests; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely Alzheimer disease and other neurodegenerative diseases and, cancer; biopharmaceutical products namely reagents, consumables, chemical entities and compounds for diagnosing, preventing and treating diseases namely Alzheimer disease and other neurodegenerative diseases and cancer ; chemical preparations for medical, pharmaceutical or veterinary purposes namely chemicals for diagnosing Alzheimer disease and other neurodegenerative diseases and cancer, especially chemical preparations for diagnosing diseases in the nature of neurodegenerative diseases and cancers; medical diagnostic products and clinical diagnostic products, namely probes and kits for medical and clinical diagnosis comprised of nucleic acid libraries and nucleic acids on DNA chips; DNA libraries and RNA libraries for medical diagnostic purposes; nucleic acid sequences intended for use in chips for medical purposes and medical diagnostic purposes, namely for decoding genes affected by diseases or revealing the transcriptomic signature of patients affected by diseases; enzymes or enzyme preparations for medical or veterinary purposes namely enzyme stabilizers and enzymatic substrates for use as ingredients in medicines for the treatment of diseases; reagents contained in diagnostic test kits for medical use for taking blood samples required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions
GS0101	Surgical, medical, dental and veterinary apparatus and instruments, particularly for identifying, assessing the seriousness of, assessing prognoses of, and measuring the progression of diseases, namely, Alzheimer disease and other neurodegenerative diseases, and cancer; medical devices using DNA chips for analyzing blood; apparatus for analyzing blood; apparatus intended for medical diagnosis, namely, materials for taking blood contained in kits for taking blood samples and comprised of medical instruments for taking blood; medical instruments for taking blood, collecting of DNA for diagnosing diseases, and materials required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions, namely, tubes, syringes and storage containers; spoons for administering medicine; specially adapted containers for the application of medicines, namely, small bags and pouches for use in administering medicines; probes for medical purposes; syringes for medical purposes
GS0421	Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analyses; chemical research; chemical services namely analysis of RNA genes, tissues and blood samples; biotechnological scientific project studies for identifying people suffering from diseases and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments, especially personalized treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analyses, namely quantification of nucleic acid content intended for medical and scientific research; consultancy in the field of biotechnology
GS0441	Medical services; veterinary services; medical assistance services; consultancy in the field of pharmacy, namely, to assist in the selection of individuals affected by diseases for the purpose of clinical trials and to offer targeted care solutions and personalized treatments; hospitals; pharmaceutical industry services, namely, to provide advice in the fields of biotechnology and pharmacy; and pharmacist's services to make up prescriptions, namely, geriatric and/or neurological services, in order to facilitate diagnoses and treatment; health care; telemedicine services

INTERNATIONAL REGISTRATION
International Registration Number	1112857
International Registration Date	11/30/2011
International Publication Date	05/10/2012
International Renewal Date	11/30/2021
Auto protection	11/03/2013
International Status Code	001 - Request for extension of protection established
International Status Date	05/03/2012
Priority Claimed In	Yes
Priority Claimed Date	06/01/2011
First Refusal In	Yes

TRADEMARK DESIGN SPECIFICATION:
26.17.01 - Bands, straight; Bars, straight; Lines, straight; Straight line(s), band(s) or bar(s)
26.17.04 - Bands, vertical; Bars, vertical; Lines, vertical; Vertical line(s), band(s) or bar(s)

PROSECUTION HISTORY
Date	Description	Type	Code
09/21/2012	TEAS REQUEST FOR RECONSIDERATION RECEIVED	I - Incoming Correspondence	ERFR
08/27/2012	NOTIFICATION OF FINAL REFUSAL EMAILED	O - Outgoing Correspondence	GNFN
08/27/2012	FINAL REFUSAL E-MAILED	O - Outgoing Correspondence	GNFR - FINAL REFUSAL E-MAILED
08/27/2012	FINAL REFUSAL WRITTEN	R - Renewal	CNFR - FINAL REFUSAL WRITTEN
07/23/2012	TEAS CHANGE OF CORRESPONDENCE RECEIVED	I - Incoming Correspondence	TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/23/2012	TEAS/EMAIL CORRESPONDENCE ENTERED	I - Incoming Correspondence	TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
09/21/2012	TEAS/EMAIL CORRESPONDENCE ENTERED	I - Incoming Correspondence	TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
09/21/2012	CORRESPONDENCE RECEIVED IN LAW OFFICE	I - Incoming Correspondence	CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
07/23/2012	CORRESPONDENCE RECEIVED IN LAW OFFICE	I - Incoming Correspondence	CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
07/23/2012	TEAS RESPONSE TO OFFICE ACTION RECEIVED	I - Incoming Correspondence	TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2012	REFUSAL PROCESSED BY IB	P	RFNT - REFUSAL PROCESSED BY IB
05/18/2012	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	P	RFCS - REFUSAL SENT TO IB
05/18/2012	REFUSAL PROCESSED BY MPU	P	RFRR
05/17/2012	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	E	RFCR - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/16/2012	NON-FINAL ACTION WRITTEN	R - Renewal	CNRT - NON-FINAL ACTION WRITTEN
05/14/2012	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
05/08/2012	APPLICATION FILING RECEIPT MAILED	O - Outgoing Correspondence	MAFR
05/04/2012	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
05/04/2012	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
05/03/2012	SN ASSIGNED FOR SECT 66A APPL FROM IB	M	REPR - SN ASSIGNED FOR SECT 66A APPL FROM IB

Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.